Thiazolidinedione
Full Form of TZD
What is TZD?
Thiazolidinediones, commonly abbreviated as TZDs, represent an important class of oral antidiabetic medications primarily prescribed for the management of type 2 diabetes mellitus. These drugs function by activating peroxisome proliferator-activated receptor gamma (PPAR-γ) in adipose tissue, muscle, and liver, thereby improving insulin sensitivity and reducing blood glucose levels without directly stimulating insulin secretion. Popular TZDs available across Indian pharmacies include pioglitazone and rosiglitazone, often prescribed as monotherapy or in combination with metformin or sulfonylureas when first-line treatment fails to achieve adequate glycemic control. Healthcare professionals throughout India frequently use the TZD abbreviation in clinical notes, prescription discussions, and pharmacology lectures, particularly in tertiary hospitals, diabetes care centres, and endocrinology departments. The class is generally reserved for patients who cannot tolerate metformin or require additional glucose-lowering support, though concerns regarding fluid retention, weight gain, and cardiovascular risks have led to more cautious prescribing practices in recent years. For medical and pharmacy students preparing for entrance examinations such as NEET PG, AIIMS, and other competitive exams, understanding the mechanism, side effects, and contraindications of TZDs remains a high-yield topic in pharmacology and endocrinology sections.
TZD का फुल फॉर्म
थायाज़ोलिडाइनडायोन
Example
Dr. Sharma prescribed pioglitazone, a TZD, to the patient along with metformin to better control her type 2 diabetes and improve insulin sensitivity.